|
|
English
version
For å registrere i Cristin må du være vitenskapelig eller administrativt ansatt.
|
|
|
|
|
|
|
|
|
2019
|
1. |
Drivenes, Karin; Haaland, Vegard Øksendal; Mesel, Terje; Tanum, Lars Håkon Reiestad. Practitioners' positive attitudes promote shared decision-making in mental health care. Journal of Evaluation In Clinical Practice 2019 ;Volum 25. s. 1041-1049 OSLOMET APOTEKSØ UiO SSHF UIA AHUS
Untitled
|
|
2. |
Khoonsari, Payam Emaami; Musunri, Sravani; Herman, Stephanie; Svensson, Camilla I; Tanum, Lars Håkon Reiestad; Gordh, Torsten; Kultima, Kim. Systematic analysis of the cerebrospinal fluid proteome of fibromyalgia patients. Journal of Proteomics 2019 ;Volum 190. s. 35-43 AHUS
Untitled
|
|
3. |
Latif, Zill-E-Huma; Solli, Kristin Klemmetsby; Opheim, Arild; Kunøe, Nikolaj; Saltyte Benth, Jurate; Krajci, Peter; Haase, Kamni Sharma; Tanum, Lars Håkon Reiestad. No increased pain among opioid-dependent individuals treated with extended-release naltrexone or buprenorphine-naloxone: A 3-month randomized study and 9-month open-treatment follow-up study. American Journal on Addictions 2019 ;Volum 38.(2) s. 77-85 UiB AHUS UiO HAUKELAND OUS
Untitled
|
|
4. |
Lind, Anne-Li; Just, David; Mikus, Maria; Fredolini, Claudia; Ioannou, Marina; Gerdle, Björn; Ghafouri, Bijar; Bäckryd, Emmanuel; Tanum, Lars Håkon Reiestad; Gordh, Torsten; Månberg, Anna. CSF levels of apolipoprotein C1 and autotaxin found to associate with neuropathic pain and fibromyalgia. Journal of Pain Research 2019 ;Volum 12. s. 2875-2889 AHUS
Untitled
|
|
5. |
Skjærvø, Ingeborg; Latif, Zill-E-Huma; Solli, Kristin Klemmetsby; Tanum, Lars Håkon Reiestad. Forekomst av kronisk smerte blant opioidavhengige. Vettre-seminaret; 2019-11-14 - 2019-11-15 AHUS UiO
Untitled
|
|
6. |
Solli, Kristin Klemmetsby; Kunøe, Nikolaj; Latif, Zill-E-Huma; Haase, Kamni Sharma; Opheim, Arild; Krajci, Peter; Gaulen, Zhanna; Saltyte Benth, Jurate; Tanum, Lars Håkon Reiestad. Availability of extended-release naltrexone may increase the number of opioid-dependent individuals in treatment: Extension of a randomized clinical trial. European Addiction Research 2019 ;Volum 25.(6) s. 1-7 SIV AHUS OUS UiO HAUKELAND UiB OSLOMET
Untitled
|
|